Browse medicines, page 32 of 37

Use listed on the medicine record

Cleansing of the colon as a preparation for colonoscopy

Use listed on the medicine record

Hyperkalemia

Use listed on the medicine record

Sodium tetradecyl sulfate injection is indicated in the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves. The benefit- to-risk ratio should be considered in selected patients who are great surgical risks.

Use listed on the medicine record

Documented, life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia

Use listed on the medicine record

: Cleanse skin to remove impurities. 2: Apply appropriate amount post - cleansing. 3: Use before heavy moisturizers or oils for better absorption.

Use listed on the medicine record

Lead poisoning

Use listed on the medicine record

Infections due to susceptible strains of the designated microorganisms in the conditions listed below

Use listed on the medicine record

Tinea cruris and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum canis

Use listed on the medicine record

Moderate to severe acute pain, including postoperative pain

Use listed on the medicine record

Reducing elevated intraocular pressure

Use listed on the medicine record

Sunscreen barrier: fully blocks UV rays and protects skin health. Deep moisturizing: prevents dryness and keeps skin moisturized. Sports adaptability: swimming and fitness without makeup removal, more lasting protection. Lightweight and comfortable: silky and fits the skin, no burden to the touch. Suitable for daily commuting, can be used alone or as a primer before makeup. Mild formula reduces irritation, sensitive skin friendly. Improves skin smoothness and soft touch. Light texture, does not clog pores. Suitable for a variety of skin types and skin tones, easy to control.

Use listed on the medicine record

For temporary relief of symptoms due to swelling of wrist, pain and swelling of knees; joints red, swollen, and hot; pain in the big toe.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Use listed on the medicine record

The incidence of catheter-related bloodstream infections

Use listed on the medicine record

Onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes

Use listed on the medicine record

Tazarotene cream, 0.1% is indicated as an adjunctive agent for use in the mitigation (palliation) of facial fine wrinkling, facial mottled hyper-and hypopigmentation, and benign facial lentigines in patients who use comprehensive skin care and sunlight avoidance programs. Tazarotene cream, 0.1% is a retinoid indicated as an adjunctive agent for use in the mitigation (palliation) of facial fine wrinkling, facial mottled hyper- and hypopigmentation, and benign facial lentigines in patients who use comprehensive skin care and sunlight avoidance programs.

Use listed on the medicine record

Human smallpox disease

Use listed on the medicine record

The following infections

Use listed on the medicine record

The short-term treatment of insomnia

Use listed on the medicine record

The signs and symptoms of benign prostatic hyperplasia

Use listed on the medicine record

To reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Use listed on the medicine record

Redness of the eye due to minor eye irritations

Use listed on the medicine record

• treats vaginal yeast infections

Use listed on the medicine record

Cystine stone formation

Use listed on the medicine record

Relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies

Use listed on the medicine record

Spasticity

Use listed on the medicine record

Clinically significant hypervolemic and euvolemic hyponatremia (serum sodium <125 mEq/L or less marked hyponatremia that is symptomatic

Use listed on the medicine record

Symptoms of depression

Use listed on the medicine record

Hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis pilaris, keratosis palmaris

Use listed on the medicine record

VABOMERE (meropenem and vaborbactam) is a combination of meropenem, a penem antibacterial, and vaborbactam, a beta-lactamase inhibitor, indicated for the treatment of patients 18 years and older with complicated urinary tract infections (cUTI) including pyelonephritis caused by designated susceptible bacteria. ( 1.1 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of VABOMERE and other antibacterial drugs, VABOMERE should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. ( 1.2 ) 1.1.

Use listed on the medicine record

Intravesical therapy of BCG-refractory carcinoma in situ (CIS) of the urinary bladder

Use listed on the medicine record

Erectile dysfunction

Use listed on the medicine record

Major depressive disorder

Use listed on the medicine record

ROMVIMZA is indicated for treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity. ROMVIMZA is a kinase inhibitor indicated for treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity. ( 1 )

Use listed on the medicine record

Vinblastine Sulfate Injection is indicated in the palliative treatment of the following: I. Frequently Responsive Malignancies • Generalized Hodgkin’s disease (Stages III and IV, Ann Arbor modification of Rye staging system) • Lymphocytic lymphoma (nodular and diffuse, poorly and well differentiated) • Histiocytic lymphoma • Mycosis fungoides (advanced stages) • Advanced carcinoma of the testis • Kaposi’s sarcoma • Letterer-Siwe disease (histiocytosis X) II.

Use listed on the medicine record

Metastatic NSCLC Vinorelbine Injection is a vinca alkaloid indicated

Use listed on the medicine record

Cutaneous manifestations

Use listed on the medicine record

Complicated urinary tract infections (cUTI) including pyelonephritis caused by designated susceptible microorganisms

Use listed on the medicine record

Locally advanced or metastatic ROS1 -positive non-small cell lung cancer (NSCLC) who received a prior ROS1 kinase inhibitor

Use listed on the medicine record

KOMZIFTI is indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible nucleophosmin 1 ( NPM1 ) mutation who have no satisfactory alternative treatment options [see Dosage and Administration ( 2.1 ), Clinical Pharmacology ( 12.1 ), and Clinical Studies ( 14 )] . KOMZIFTI is a menin inhibitor indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible nucleophosmin 1 ( NPM1 ) mutation who have no satisfactory alternative treatment options. ( 1 )